Department of Ophthalmology, Aarhus University Hospital
Aarhus, 8000, Denmark
NCT Number: NCT01689090
The primary objective is to study if an inhibition of nitric oxide and/or prostaglandins affect the diameter changes of retinal vessels observed during hypoxia. Diameter changes are studied using the Dynamic Vessel Analyzer.
Looking for future studies?
Notify Me20 year–65 year
All sexes
Interventional
Not applicable
Aarhus, 8000, Denmark
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administration of 1 drop voltaren 45 minutes before recordings of diameter changes of retinal vessels are initiated
Other names: Eye drops voltaren 1 mg/ml
Intravenous administration of L-NMMA during recordings of diameter changes of retinal vessels
Other names: L-NMMA
Combination of interventions. Administration of an eye drop voltaren and 45 minutes later infusion with L-NMMA is started and recording of diameter changes of retinal vessels is performed
Time frame: Examination day 1 and 2
Comparing the differences of diameter changes occuring during each of the interventions.
University of Aarhus
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02624804
Autoimmune Diseases, Diabetes Mellitus
Hackensack, New Jersey, United States
View Trial DetailsNCT07015970
Autoimmune Diseases, Diabetes Mellitus
Caen, France
View Trial DetailsNCT06088615
Autoimmune Diseases, Diabetes Mellitus
Ulm, Baden-Wurttemberg, Germany
View Trial DetailsNCT00006505
Autoimmune Diseases, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial Details